Patent ID: 9676819
Date: 2017-06-13
CPC Classifications: A61K,A61P,C07K,Y02A

Claim:
1. A method for preventing or treating a respiratory condition associated with one or more viral infectious agents in a subject, the method comprising: administering to the respiratory tract of the subject a composition comprising a soluble TLR2 moiety comprising a TLR2 agonist and a solubilizing agent that increases the solubility of the TLR2 agonist in polar or aqueous solvents, thereby preventing or treating the respiratory condition in the subject, wherein the moiety raises an innate immune response in the subject and does not raise an immune response that is specific for an antigen of the one or more infectious agents, wherein the composition does not contain a peptide antigen comprising a T-helper epitope, and wherein the TLR2 agonist is a lipopeptide.